Pulmonary Tuberculosis II
Pneumothorax-II
Pulmonary Tuberculosis V
COPD: Pathogenesis and Clinical Features
Pulmonary Cycle: Exhalation
Cystic Fibrosis: Management
您也可能阅读
通过共同作者、期刊和引用图与本文相关的文章。
Khalid Mahmood1, Nauman Ismat Butt1, Fahmina Ashfaq2
1Department of Medicine & Allied, Azra Naheed Medical College, Superior University, Lahore, Pakistan.
耐火性肺部沙尔科毒症需要先进的免疫抑制疗法. 这一案例突出了利图西马布作为对多种常规和生物药物无反应的患者的潜在治疗选择.
科学领域:
背景情况: